Assembly Biosciences, Inc. Proceeds from Lines of Credit
Assembly Biosciences, Inc. (ASMB) reported Proceeds from Lines of Credit of $419.38 thousand for the 78-month period ending 2012-03-31, per its 10-Q filed 2012-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2012-05-09
- Assembly Biosciences, Inc. proceeds from lines of credit for the quarter ending 2011-09-30 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 69 month | Proceeds from Lines of Credit 72 month | Proceeds from Lines of Credit 78 month |
|---|---|---|---|---|
| 2012-03-31 | $419.38K 10-Q · filed 2012-05-09 | |||
| 2011-09-30 | $0.00 derived: 10-Q/A 72 month − 10-Q 69 month · filed 2011-11-18 | $419.38K 10-Q/A · filed 2011-11-18 | ||
| 2011-06-30 | $419.38K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |